2013 New Drug Update: What Do New Approvals Hold for the Elderly?
Abstract:Six new drugs that are used for medical problems often experienced by the elderly have been selected for consideration in this review. The uses and most important properties of these agents are reviewed, and a rating for each new drug is determined. The rating is based on a comparison of the new drug with related drugs already marketed. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating.
Keywords: ACEI = Angiotensin-converting enzyme inhibitor; ARB = Angiotensin receptor blocker; Alogliptin; Anorexiant; Antiarthritic agent; Anticoagulant; Apixaban; Atrial fibrillation; BMI = Body mass index; Bronchodilator; COPD = Chronic obstructive pulmonary disease; CYP = Cytochrome P450; Canagliflozin; DMARD = Disease-modifying antirheumatic drug; DPP-4 = Dipeptidyl peptidase 4; DVT = Deep vein thrombosis; Diabetes; Elderly; FDA = Food and Drug Administration; Fluticasone; HbA1C = Hemoglobin A1C; INR = International normalized ratio; JAK = Janus kinases; LABA = Long-acting beta2-adrenergic receptor agonist; Lorcaserin; MDRD = Modification of diet in renal disease; MI = Myocardial infarction; NDCR = New Drug Comparison Rating; P-gp = P-glycoprotein; PE = Pulmonary embolism; Phentermine; SGLT2 = Sodium-glucose co-transporter 2; SNRI = Serotonin norepinephrine reuptake inhibitor; T2DM = Type 2 diabetes mellitus; TNF = Tumor necrosis factor; Tofacitinib; Topiramate; UGT = Uridine diphosphate glucuronosyl transferase; Vilanterol; eGFR = Estimated glomerular filtration rate
Document Type: Research Article
Publication date: April 1, 2014
- The Consultant Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists. It is dedicated exclusively to the medication needs of the elderly in all settings, including adult day care, ambulatory care, assisted living, community, hospice, and nursing facilities. This award-winning journal is a member benefit of ASCP. Individuals who are not members and wish to receive The Consultant Pharmacist® will want to consider joining ASCP.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites